As of 2024-12-11, the Relative Valuation of Meridian Bioscience Inc (VIVO) is 41.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.97 USD, the upside of Meridian Bioscience Inc based on Relative Valuation is 21.0%.
The range of the Relative Valuation is 36.80 - 47.99 USD.
| Range | Selected | |
| Trailing P/E multiples | 38.1x - 49.7x | 43.2x |
| Forward P/E multiples | 33.1x - 36.0x | 35.4x |
| Fair Price | 36.80 - 47.99 | 41.11 |
| Upside | 8.3% - 41.3% | 21.0% |
| Date | P/E |